Glucagon-like peptide-1 receptor agonists versus naltrexone, acamprosate, or disulfiram for adults with type 2 diabetes and comorbid alcohol use disorder: a target trial emulation study

OSF Preprints (OSF Preprints) 2026 Preprint

Authors: Joshua David Wallach, Samuel T. Savitz

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Substance Abuse Treatment and Outcomes Diabetes Management and Research